Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis

BACKGROUND: Sodium consumption is a modifiable risk factor for higher blood pressure (BP) and cardiovascular disease (CVD). The US Food and Drug Administration (FDA) has proposed voluntary sodium reduction goals targeting processed and commercially prepared foods. We aimed to quantify the potential...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:PLoS Med
Κύριοι συγγραφείς: Pearson-Stuttard, Jonathan, Kypridemos, Chris, Collins, Brendan, Mozaffarian, Dariush, Huang, Yue, Bandosz, Piotr, Capewell, Simon, Whitsel, Laurie, Wilde, Parke, O’Flaherty, Martin, Micha, Renata
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2018
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892867/
https://ncbi.nlm.nih.gov/pubmed/29634725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002551
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια